Primaxin
Product Images NDC 0006-3552

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Primaxin (NDC 0006-3552). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Primaxin Iv 01)

FDA Label Image

Chemical Structure (Primaxin Iv 02)

FDA Label Image

Principal Display Panel 250 mg Bottle Label (Primaxin Iv 03)

FDA Label Image

Principal Display Panel 500 mg Bottle Label (Primaxin Iv 04)

This is a package of Primaxin® IV, containing 500mg of imipenem, 500mg of cilastatin, and 20mg of sodium bicarbonate used as a buffer. The solution is for intravenous use only and should not be directly infused. The usual adult dosage and preparation instructions can be found in the accompanying circular. The color change of the solution from colorless to yellow does not affect potency. The package contains a single-dose vial with a serialization barcode, expiration date, and lot number. It should be stored below 25°C. This product is manufactured by Merck Sharp & Dohme LLC, based in Rahway, NJ, and is available only with a prescription.*

FDA Label Image

Single-dose Add-vantage Vial 250 mg (Primaxin Iv 05)

FDA Label Image

Single-dose Add-vantage Vial 500 mg (Primaxin Iv 06)

This is a description of a medication called Primaxinci, which includes Imipenem 500mg and Cilastatin, for injection. It comes in a single-dose vial and is cautioned not to be used for direct infusion. The trademark of Merc S1ar & Dot Gor and the registered trademark of ABBOTT LABORATORIES Inc are also included. No other information is available.*

FDA Label Image

Primaxin Iv 07

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.